Pro-Med wins patent dispute against Fresenius-Kabi
This article was originally published in Clinica
Executive Summary
A small Austrian drug delivery company has won a preliminary injunction against its heavyweight rival Fresenius-Kabi, barring the latter from selling and marketing its Ambix Anapa infusion pump in Germany.